EndoGastric Solutions Closes $21.5m Series E Financing

EndoGastric Solutions, Inc. (EGS), a Redwood City, CA-based developer of new transoral procedures and products to address gastrointestinal diseases, closed a $21.5m Series E financing led by current investors including Advanced Technology Ventures.
The company is pioneering endoluminal procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and other GI disorders.
In the past 6 months, EGS has increased its sales and marketing organization to support 30 territories nationwide, and to include a complete marketing, training and reimbursement team.
The funds will be used to support commercial expansion for the company’s Natural Orifice Surgery (NOS) platform, which includes the EsophyX and StomaphyX surgical devices.

Join the discussion